• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (BROKEN BOW) BD VACUTAINER® CPT¿ NH: ~130 IU FICOLL¿: 2.0ML; BLOOD SPECIMEN COLLECTION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (BROKEN BOW) BD VACUTAINER® CPT¿ NH: ~130 IU FICOLL¿: 2.0ML; BLOOD SPECIMEN COLLECTION DEVICE Back to Search Results
Catalog Number 362780
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/15/2023
Event Type  malfunction  
Manufacturer Narrative
There were multiple lot numbers reported to be involved.The information for each additional lot number is as follows: d4.Medical device lot #: 2341889; d4.Medical device expiration date: 2023-12-31; h4.Device manufacture date: 2022-12-07.D4.Medical device lot #: 3024227; d4.Medical device expiration date: 2024-01-31; h4.Device manufacture date: 2023-01-24.D4.Medical device lot #: 3046964; d4.Medical device expiration date: 2024-02-29; h4.Device manufacture date: 2023-02-15.D4.Medical device lot #: 3046965; d4.Medical device expiration date: 2024-02-29; h4.Device manufacture date: 2023-02-15.D4.Medical device lot #: 3142380; d4.Medical device expiration date: 2024-05-31; h4.Device manufacture date: 2023-05-22.H.3.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that while using bd vacutainer® cpt¿ nh: ~130 iu ficoll¿: 2.0ml that there was poor barrier separation of sample/ insufficient additive quantity.The following information was provided by the initial reporter: medpace is collecting blood samples from patients and controls.In europe they encounter issues with red blood cell contamination and slanted gel barriers.This is not related to a specific patient group as it can be seen in healthy controls as well.
 
Manufacturer Narrative
Material #: 362780.Lot/batch #: 2341889, 3142380, 3024227, 3046964, 3046965, and 3142380.Bd had not received samples or photos for evaluation.Therefore, 59 retention samples of the incident lots were selected from bd inventory for evaluation and upon completion, no issues relating to poor barrier separation or poor plasma were observed.Complaints for sample quality were not under statistical control for the month of august 2023, therefore additional clinical testing was required.No difficulties were encountered during blood collection and all tubes exhibited proper fill.Bd was unable to duplicate or confirm the customer¿s indicated failure modes (poor barrier separation, poor plasma) because the defect was not evident in the testing of the complaint lot samples.Replicates of both retention and control samples tested demonstrated clinically acceptable performance for all visual observations evaluated.All tubes performed as expected.Based on a review of the device history record for the incident lot, all product specifications and requirements for lot release were met.There were no related quality issues during manufacturing of the product.This complaint is unable to be confirmed for the indicated failure mode poor barrier separation or poor plasma.Bd was not able to identify a root cause for the indicated failure mode.Complaints received for this device and reported condition will continue to be tracked and trended.Our business team regularly reviews the collected data for identification of emerging trends.
 
Event Description
It was reported that while using bd vacutainer® cpt¿ nh: ~130 iu ficoll¿: 2.0ml that there was poor barrier separation of sample/ insufficient additive quantity.The following information was provided by the initial reporter: medpace is collecting blood samples from patients and controls.In europe they encounter issues with red blood cell contamination and slanted gel barriers.This is not related to a specific patient group as it can be seen in healthy controls as well.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD VACUTAINER® CPT¿ NH: ~130 IU FICOLL¿: 2.0ML
Type of Device
BLOOD SPECIMEN COLLECTION DEVICE
Manufacturer (Section D)
BECTON, DICKINSON & CO. (BROKEN BOW)
150 south 1st avenue
broken bow NE 68822
Manufacturer (Section G)
BECTON, DICKINSON & CO. (BROKEN BOW)
150 south 1st avenue
broken bow NE 68822
Manufacturer Contact
jennifer suh
5859 farinon drive
san antonio, TX 78249
8448235433
MDR Report Key17671401
MDR Text Key322528472
Report Number1917413-2023-00862
Device Sequence Number1
Product Code JCF
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number362780
Device Lot NumberSEE H.10
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/15/2023
Initial Date FDA Received09/01/2023
Supplement Dates Manufacturer Received11/10/2023
Supplement Dates FDA Received11/27/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-